ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CTNM Contineum Therapeutics Inc

14.09
-0.25 (-1.74%)
22 Nov 2024 - Closed
Delayed by 15 minutes

Contineum Therapeutics Financial Summary

The current CTNM market cap is 363.21M. The company's latest EPS is USD 0.8814 and P/E is 15.99.

Quarter End Mar 2024Jun 2024
USD (US$)
Total Revenue 00
Operating Income -9.93M-10.94M
Net Income -8.42M-9.01M
Year End 31 December 2023 2023
USD (US$)
Total Revenue 50M
Operating Income 16.08M
Net Income 22.72M
Quarter End Mar 2024Jun 2024
USD (US$)
Total Assets 123.56M221.36M
Total Liabilities 6.57M3.85M
Total Equity -75.63M217.5M
Year End 31 December 2023 2023
USD (US$)
Total Assets 130.39M
Total Liabilities 5.7M
Total Equity -67.94M
Quarter End Mar 2024Jun 2024
USD (US$)
Operating -7.98M-16.47M
Investing 8.73M-30.17M
Financing -18k108.35M
Year End 31 December 2023 2023
USD (US$)
Operating 19.35M
Investing -65.57M
Financing 56.18M
Market Cap 363.21M
Price to Earnings Ratio 15.99
Price to Sales Ratio 7.26
Price to Cash Ratio 23.39
Price to Book Ratio 2.91
Dividend Yield -

Share Statistics

Shares Outstanding 25.78M
Average Volume (1 week) 74.81k
Average Volume (1 Month) 76.82k
52 Week Change -2.83%
52 Week High 22.00
52 Week Low 12.33
Spread (Intraday) 2.18 (13.4%)

Company Info

Company Name Contineum Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.contineum-tx.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock